Amid Humanitarian Crisis in India, Merck Announces Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19 Pharmaceutical Investing
PLUG, WKHS & BLU Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Biotech Investing
Merck Accelerates Climate Goals; Announces Carbon Neutrality in Operations by 2025 Pharmaceutical Investing
Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants Cannabis Investing News
Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab Cannabis Investing News
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm Biotech Investing
ROSEN, A RESPECTED LAW FIRM, Encourages BELLUS Health Inc. Investors With Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision Medical Device Investing
Bristol Myers Squibb Presents Positive Data from Two Pivotal Phase 3 Psoriasis Studies Demonstrating Superiority of Deucravacitinib Compared to Placebo and Otezla® Biotech Investing
AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy Biotech Investing
